Amrutanjan Health Care Ltd

Amrutanjan Health Care Ltd | Sector: Pharmaceuticals | ISIN: INE098F01031

₹ 712.70 (0.37%) icon

27 Jan, 2023, 3:43:56 PM
Open
₹ 706.00
Prev. Close
₹ 710.05
Turnover(lac)
₹ 103.55
Day's High
₹ 715.00
Day's Low
₹ 704.55
52 Wk High
₹ 954.60
52 Wk Low
₹ 688.00
Book Value
₹ 96.32
Face Value
₹ 1.00
Mkt. Cap (Cr.)
₹ 2,083.27
P/E
40.27
EPS
17.69
Div. Yield
0.65

KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 1/27/2023 3:43:56 PM

    ₹ 712.7 2.65 0.37
  • Open
  • ₹ 706
  • Prev. Close
  • ₹ 710.05
  • Turnover(Lac.)
  • ₹ 104
  • Day's High
  • ₹ 715
  • Day's Low
  • ₹ 704.55
  • 52 Week's High
  • ₹ 954.6
  • 52 Week's Low
  • ₹ 688
  • Book Value
  • ₹ 96.32
  • Face Value
  • ₹ 1
  • Mkt Cap (₹ Cr.)
  • 2,083.27
  • P/E
  • 40.27
  • EPS
  • 17.69
  • Divi. Yield
  • 0.65

Corporate Actions

04 Nov , 2022

12:00 AM

Dividend

Dividend amount: 1
Announcement date: 04 Nov , 2022

View Details

27 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

27 Oct , 2022

12:00 AM

19 Aug , 2022

12:00 AM

AGM

Announcement date: 19 Aug , 2022

View Details

24 May , 2022

12:00 AM

Dividend

Dividend amount: 2.6
Announcement date: 24 May , 2022

View Details

04 Aug , 2022

12:00 AM

04 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

17 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

11 Feb , 2022

12:00 AM

Dividend

Dividend amount: 1
Announcement date: 11 Feb , 2022

View Details

04 Feb , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Feb , 2022

12:00 AM

17 Aug , 2022

12:00 AM

BookCloser

View Details

SHAREHOLDING SNAPSHOT
28 January , 2023 | 12:35 AM

PROMOTER - TOTAL50.02%

Indian: 50.02%

Foreign: 0%

NON-PROMOTER - TOTAL 49.80%

Institutions: 7.14%

Non-Institutions: 42.65%

CUSTODIES - 0.18%

Custodies: 0.18%

See More Details

Invest wise with Expert advice

Amrutanjan Health Care Ltd News and Update

Image not found
  • 24 January, 2023 |
  • 2:39 PM

LYFE, designed by leading Indian cardiologists, assists patients in improving their heart health through doctor-connected online and offline modules

Article Image
  • IIFL News Service |
  • 23 January, 2023 |
  • 2:37 PM
Image not found
  • IIFL News Service |
  • 23 January, 2023 |
  • 2:37 PM
Image not found
  • IIFL News Service |
  • 20 January, 2023 |
  • 2:33 PM
ad IconAd Image

FINANCIALS

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Amrutanjan Health Care Ltd

  • Pasumarthi S N Murthi

  • Director
  • S Sambhuprasad

  • Chairman & Managing Director
  • Marie Shiranee Pereira

  • Independent Director
  • S Vydeeswaran

  • Independent Director
  • G Raghavan

  • Independent Director
  • M Srinivasan

  • Company Sec. & Compli. Officer
  • V Raja

  • Independent Director
  • Muralidharan Swayambunathan

  • Independent Director
  • Meena Lochani Raghunathan

  • Independent Director

Summary

The Madras-based Amrutanjan manufactures bulk drugs and drug intermediateslike theophylline, based on in-house research. Three plants have been set up in the Alandur industrial belt near Madras to produce these products. It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore. Pheromones have found wide application as pesticides and are used on cotton crops.Amrutanjan also has an agreement with a company in Philadelphia, US, to supply custom-made chemicals for exotic applications like the genetic manipulation of biological matter. It has introduced some new range of products like Pep Pill, Amrutanjan gripe water sans alcohol, Amrutanjan Maha Strong, etc. Plans are afoot to introduce analgesic and antipyretic tablets. The company also plans to launch sanitary napkins soon. The company has approached the US FDA for approval and clearance to sell its new drugs in US. During 1996-97, it has introduced a new product called Cold Snap Gel and also a mint called tingle. Company having two subsidiary companies viz. Amrutanjan Drugs & Chemicals Ltd having holding stake 99.80% & Amrutanjan Finance Ltd, having holding stake is 57.26%.Company has taken efforts to increase the export of fine chemicals & also taking major efforts to give full thrust to existing products. Amrutanjan also modernising its OTC business and expanding its export of fine chemicals which reflects to turnover & net Profit of the... Read More


Reports by Amrutanjan Health Care Ltd


Reports by Amrutanjan Health Care Ltd